Advances in genetics: widening our understanding of prostate cancer. - PubMed - NCBI

Advances in genetics: widening our understanding of prostate cancer. - PubMed - NCBI

F1000Res. 2016 Jun 27;5. pii: F1000 Faculty Rev-1512. doi: 10.12688/f1000research.8019.1. eCollection 2016.

Advances in genetics: widening our understanding of prostate cancer.

Pine AC1, Fioretti FF2, Brooke GN3, Bevan CL2.

Author information

Abstract

Prostate cancer is a leading cause of cancer-related death in Western men. Our understanding of the genetic alterations associated with disease predisposition, development, progression, and therapy response is rapidly improving, at least in part, owing to the development of next-generation sequencing technologies. Large advances have been made in our understanding of the genetics of prostate cancer through the application of whole-exome sequencing, and this review summarises recent advances in this field and discusses how exome sequencing could be used clinically to promote personalised medicine for prostate cancer patients.

KEYWORDS:

Androgen; Cancer progression; DNA damage repair; Metastasis; Personalised Medicine; Prostate Cancer; Transcriptome; WES; Whole Exome Sequencing

PMID:

 

27408704

 

PMCID:

 

PMC4926757

 

DOI:

 

10.12688/f1000research.8019.1

[PubMed] 

Free PMC Article

Public Health Genomics Knowledge Base (v1.2)

PROSTATE CANCER

Last Updated: Sep 08, 2016

• Advances in genetics: widening our understanding of prostate cancer.
  Pine Angela C et al. F1000Research 2016 5
• Prostate Cancer Awareness 
• Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis.
  Wang Kewei, et al. BMC cancer 2016 0 (1) 674
• The association between MMP2 -1306 C > T (rs243865) polymorphism and risk of prostate cancer.
  Shajarehpoor Salavati L, et al. Irish journal of medical science 2016 8
• Use of a novel non-parametric version of DEPTH to identify genomic regions associated with prostate cancer risk.
  MacInnis Robert J, et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016 8
• A comprehensive analysis of genome-wide association studies to identify prostate cancer susceptibility loci for the Romanian population.
  R?d?voi George Daniel, et al. Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2016 0 (2) 467-75
• Association between 17q25.3-rs6465657 polymorphism and prostate cancer susceptibility: a meta-analysis based on 19 studies.
  Jiang Xiao, et al. OncoTargets and therapy 2016 0 4491-503
• Genetic variants of the Wnt signaling pathway as predictors of aggressive disease and reclassification in men with early stage prostate cancer on active surveillance.
  Shu Xiang, et al. Carcinogenesis 2016 8
• Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.
  Kerns Sarah L, et al. EBioMedicine 2016 7
• Stakeholder consultation insights on the future of genomics at the clinical-public health interface.
  Modell Stephen M et al. Translational research : the journal of laboratory and clinical medicine 2014 May 163(5) 466-77
• eNOS gene polymorphisms in paraffin-embedded tissues of prostate cancer patients.
  Polat Fikriye, et al. Turkish journal of medical sciences 2016 0 (3) 673-9
• Polymorphisms in androgen metabolism genes AR, CYP1B1, CYP19, and SRD5A2and prostate cancer risk and aggressiveness in Bulgarian patients.
  Kachakova Darina, et al. Turkish journal of medical sciences 2016 0 (3) 626-40
• Genetic variants in RNA-induced silencing complex genes and prostate cancer.
  Nikoli? Z, et al. World journal of urology 2016 8
• Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?
  Karunasinghe Nishi, et al. BMC urology 2016 0 (1) 48
• Rare Variation in TET2 Is Associated with Clinically Relevant Prostate Carcinoma in African-Americans.
  Koboldt Daniel C, et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016 8

• CDC Information (3)
• CDC-Authored Pub (1)

• Human (17)
• Pathogen (1)

• Human (2062)
• Pathogen (0)

• Human (82)
• Pathogen (0)

• Guidelines (1)
• Tier Table (1)
• Synthesis (8)

• Huamn (5)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB